Jiang Shaotao, Wu Huijie, Fu Rongdang, Mai Jialuo, Yao Jiyou, Hua Xuefeng, Chen Huan, Liu Jie, Lu Minqiang, Li Ning
Department of HBP SURGERY II, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Department of Gynecology, The First People's Hospital of Foshan, Foshan, China.
Front Oncol. 2021 Feb 24;11:609397. doi: 10.3389/fonc.2021.609397. eCollection 2021.
Primary hepatic carcinoid tumor (PHCT) is rare and has unclear clinical characteristics and prognosis.
A retrospective study using data from the SEER database for patients diagnosed with PHCT used univariate and multivariate Cox models to screen for independent prognostic factors. The outcomes of patients in the surgical and nonsurgical groups were compared, and Propensity Score Matching (PSM) analysis was used to reduce confounder bias.
A total of 186 PHCT patients were identified and the median survival was 65 (95% CI [43.287, 86.713]) months. Tumor size(HR = 2.493, 95% CI[1.222,5.083], p = 0.012), male(HR = 1.690, 95% CI[1.144,2.497], p = 0.008), age(HR = 2.583, 95% CI[1.697,3.930], p < 0.001), SEER stage(HR = 1.555, 95% CI[1.184,2.044], p = 0.002) and surgery(HR = 0.292, 95% CI[0.135,0.634], p = 0.002) were significantly correlated with patient prognosis. In multivariate analysis, sex(HR = 3.206, 95% CI[1.311,7.834], p = 0.011) and surgery(HR = 0.204, 95% CI[0.043,0.966], p = 0.0045) were independent predictors of patient prognosis. Females are potentially susceptible to PHCT but have a better prognosis. With consistent baseline data, surgical patients have a better prognosis.
PHCT is uncommon and survival time is longer than that of other primary liver cancers. We found that none-surgery was potentially independent risk factors for poor prognosis.
原发性肝类癌肿瘤(PHCT)较为罕见,其临床特征和预后尚不清楚。
一项回顾性研究使用了监测、流行病学与最终结果(SEER)数据库中被诊断为PHCT患者的数据,采用单因素和多因素Cox模型筛选独立预后因素。比较了手术组和非手术组患者的结局,并使用倾向评分匹配(PSM)分析以减少混杂偏倚。
共识别出186例PHCT患者,中位生存期为65(95%置信区间[43.287, 86.713])个月。肿瘤大小(风险比[HR]=2.493,95%置信区间[1.222, 5.083],p=0.012)、男性(HR=1.690,95%置信区间[1.144, 2.497],p=0.008)、年龄(HR=2.583,95%置信区间[1.697, 3.930],p<0.001)、SEER分期(HR=1.555,95%置信区间[1.184, 2.044],p=0.002)和手术(HR=0.292,95%置信区间[0.135, 0.634],p=0.002)与患者预后显著相关。在多因素分析中,性别(HR=3.206,95%置信区间[1.311, 7.834],p=0.011)和手术(HR=0.204,95%置信区间[0.043, 0.966],p=0.0045)是患者预后的独立预测因素。女性可能易患PHCT,但预后较好。在基线数据一致的情况下,手术患者预后较好。
PHCT并不常见,生存时间比其他原发性肝癌更长。我们发现非手术是预后不良的潜在独立危险因素。